Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells Malignant Pancreatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (33)
Anti-Gpc3-Car Autologous T Lymphocytes Hepatocellular Carcinoma	Roswell Park Cancer Institute	P1	C (33)
Anti-Gpc3 Car-T Hepatocellular Carcinoma	Zhejiang University	P1	C (33)
Atlcar.Cd30.Ccr4 Cells Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	UNC Lineberger Comprehensive Cancer Center	P1	C (33)
Atlcar.Cd30.Ccr4 Cells Neoplasm	UNC Lineberger Comprehensive Cancer Center	P1	C (33)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Marginal Zone Lymphoma	City of Hope Medical Center	P1	C (33)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes Marginal Zone Lymphoma	City of Hope Medical Center	P1	C (33)
Car-Nk-Cd19 Cells Non-Hodgkin Lymphoma	Beijing Boren Hospital	P1	C (33)
cd19.20.22 car t cells Marginal Zone Lymphoma	University of Maryland, Baltimore	P1	C (33)
cd19.20.22 car t cells Richter Transformation	University of Maryland, Baltimore	P1	C (33)
cd19/baff-r in vivo car-t cell intravenous infusion Lymphoma	Qi deng	P1	C (33)
CD19.CAR-multiVSTs Non-Hodgkin Lymphoma	Baylor College of Medicine	P1	C (33)
cd19/cd22-bispecific car-t cells Lymphoma	Seattle Children's Hospital	P1	C (33)
cd30.car-t Primary Mediastinal Large B-Cell Lymphoma	Tessa Therapeutics	P1	C (33)
cd79b-19 car t cells Non-Hodgkin Lymphoma	Marcela V. Maus, M.D.,Ph.D.	P1	C (33)
ct011 car-gpc3 t cells Hepatocellular Carcinoma	CARsgen Therapeutics Co., Ltd.	P1	C (33)
Epc-003 Fully Human Anti-B7H3/Il13Ra2 Armored Car-T Cell Therapy Glioblastoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	C (33)
Fctx-Cl19-1 Large B-Cell Lymphoma	FamiCordTx	P1	C (33)
gb5005 cart Non-Hodgkin Lymphoma	The First Affiliated Hospital of Xiamen University	P1	C (33)
gpc3 car-t cells Hepatocellular Carcinoma	Shenzhen University General Hospital	P1	C (33)
Hucart19-Il18 Non-Hodgkin Lymphoma	University of Pennsylvania	P1	C (33)
Syncar-001 Large B-Cell Lymphoma	Synthekine	P1	C (33)
Unicar02-T Acute Myeloid Leukemia	AvenCell Therapeutics, Inc.	P1	C (33)
Anti Cd30 Car-T Cell Primary Mediastinal Large B-Cell Lymphoma	Zhejiang University	Early P1	C (33)
Anti-Ex02 Car T Cells Pancreatic Neoplasm	Zhang Xiaofeng,MD	Early P1	C (33)

Showing 2501 to 2525 of 3,186 assets

PreviousPage 101 of 128Next